<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">2985087R</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">4945</journal-id>
      <journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Genet</journal-id>
      <journal-title-group>
        <journal-title>Journal of medical genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-2593</issn>
      <issn pub-type="epub">1468-6244</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">29122926</article-id>
      <article-id pub-id-type="pmc">8215682</article-id>
      <article-id pub-id-type="doi">10.1136/jmedgenet-2017-104827</article-id>
      <article-id pub-id-type="manuscript">NIHMS1690774</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Defect in phosphoinositide signalling through a homozygous variant in <italic>PLCB3</italic> causes a new form of spondylometaphyseal dysplasia with corneal dystrophy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Ben-Salem</surname>
            <given-names>Salma</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Robbins</surname>
            <given-names>Sarah M</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sobreira</surname>
            <given-names>Nara LM</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lyon</surname>
            <given-names>Angeline</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Shamsi</surname>
            <given-names>Aisha M</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Islam</surname>
            <given-names>Barira K</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akawi</surname>
            <given-names>Nadia A</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>John</surname>
            <given-names>Anne</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thachillath</surname>
            <given-names>Pramathan</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hamed</surname>
            <given-names>Sania Al</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valle</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ali</surname>
            <given-names>Bassam R</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Gazali</surname>
            <given-names>Lihadh</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Pathology, College of Medicine and Heath Sciences, University Al-Ain, Al Ain, AbuDhabi, United Arab Emirates</aff>
      <aff id="A2"><label>2</label>Human genetics and Molecular Biology, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</aff>
      <aff id="A3"><label>3</label>Chemistry and Biological Sciences, West Lafayette, USA</aff>
      <aff id="A4"><label>4</label>Department of Paediatrics, Tawam Hospital, Al-Ain, United Arab Emirates</aff>
      <aff id="A5"><label>5</label>Department of Paediatrics, College of Medicine and Heath Sciences, United Arab Emirates University, Al Ain, United Arab Emirates</aff>
      <aff id="A6"><label>6</label>Division of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, Oxfordshire, UK</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P2"><bold>Contributors</bold> All authors made a significant contribution to data collection, data interpretation and critical assessment of this study. Specifically, SBS, SMR, NlMS, DV, BRA and AL contributed to study design and concept. LA initiated the study, recruited the family, and performed clinical evaluations of the patients. AMA helped in patients assessment and clinical tests. SBS and NLMS analyzed WES data and Sanger sequencing. SBS and SMR performed functional studies. AL and BKI have done the molecular modeling. NAA and AJ helped in Sanger sequencing. SAH helped in blood sample collection. PT isolated the genomic DNA from blood samples. LA, DV and Bra coordinated the study. all authors read and approved the final manuscript.</p>
        </fn>
        <corresp id="CR1">Correspondence to Professor Lihadh Al-Gazali, Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University Al-Ain, United arab emirates; <email>l.algazali@uaeu.ac.ae</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>4</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>21</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <volume>55</volume>
      <issue>2</issue>
      <fpage>122</fpage>
      <lpage>130</lpage>
      <!--elocation-id from pubmed: 10.1136/jmedgenet-2017-104827-->
      <abstract id="ABS1">
        <sec id="S1">
          <title>Background</title>
          <p id="P3">Bone dysplasias are a large group of disorders affecting the growth and structure of the skeletal system.</p>
        </sec>
        <sec id="S2">
          <title>Methods</title>
          <p id="P4">In the present study, we report the clinical and molecular delineation of a new form of syndromic autosomal recessive spondylometaphyseal dysplasia (SMD) in two Emirati first cousins. They displayed postnatal growth deficiency causing profound limb shortening with proximal and distal segments involvement, narrow chest, radiological abnormalities involving the spine, pelvis and metaphyses, corneal clouding and intellectual disability. Whole genome homozygosity mapping localised the genetic cause to 11q12.1&#x2013;q13.1, a region spanning 19.32 Mb with ~490 genes. Using whole exome sequencing, we identified four novel homozygous variants within the shared block of homozygosity. Pathogenic variants in genes involved in phospholipid metabolism, such as <italic>PLCB4</italic> and <italic>PCYT1A,</italic> are known to cause bone dysplasia with or without eye anomalies, which led us to select <italic>PLCB3</italic> as a strong candidate. this gene encodes phospholipase c &#x3B2; 3, an enzyme that converts phosphatidylinositol 4,5 bisphosphate (PIP<sub>2</sub>) to inositol 1,4,5 triphosphate (IP<sub>3</sub>) and diacylglycerol.</p>
        </sec>
        <sec id="S3">
          <title>Results</title>
          <p id="P5">The identified variant (c.2632G&gt;T) substitutes a serine for a highly conserved alanine within the Ha2&#x2019; element of the proximal C-terminal domain. This disrupts binding of the Ha2&#x2019; element to the catalytic core and destabilises PLCB3. Here we show that this hypomorphic variant leads to elevated levels of PIP<sub>2</sub> in patient fibroblasts, causing disorganisation of the F-actin cytoskeleton.</p>
        </sec>
        <sec id="S4">
          <title>Conclusions</title>
          <p id="P6">Our results connect a homozygous loss of function variant in <italic>PLCB3</italic> with a new SMD associated with corneal dystrophy and developmental delay (SMDCD).</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>